![Seqens](https://www.pharmacompass.com/image/flap/seqens-corp-ad-w16-desktop-header-newgif-91648.gif)
![Seqens](https://www.pharmacompass.com/image/flap/seqens-corp-ad-w16-header-mobile-newgif-14167.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2023-60327.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-15-2023-86840.pdf
https://www.clinicaltrialsarena.com/news/initiator-approval-trial-pain-reducing-effects/
https://www.prnewswire.com/news-releases/averitas-pharma-announces-fda-acceptance-of-snda-filing-for-qutenza-capsaicin-8-patch-for-the-treatment-of-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy-300976908.html
https://www.prnewswire.com/news-releases/averitas-pharma-announces-fda-acceptance-of-snda-filing-for-qutenza-capsaicin-8-patch-for-the-treatment-of-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy-300976908.html
https://www.globenewswire.com/news-release/2019/12/03/1955486/0/en/Centrexion-Therapeutics-Announces-Issuance-of-U-S-Composition-of-Matter-Patent-for-Lead-Pipeline-Candidate-CNTX-4975.html
https://www.fiercebiotech.com/biotech/kindler-s-centrexion-restarts-ipo-bid-to-fund-phase-3-pain-trial
https://www.biospace.com/article/releases/grunenthal-acquires-averitas-pharma-and-establishes-commercial-footprint-in-the-us/?s=79
https://www.prnewswire.com/news-releases/gr%C3%BCnenthal-acquires-global-rights-for-qutenza--822055403.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-30-2018-1527659653.pdf
http://www.biospace.com/News/new-fda-report-cites-22-drugs-that-passed-phase-ii/444652/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/201616/anvisa+suspende+lote+do+creme+dermatologico+moment